{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:01:36Z","timestamp":1768438896328,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["294227"],"award-info":[{"award-number":["294227"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["294229"],"award-info":[{"award-number":["294229"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["307057"],"award-info":[{"award-number":["307057"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["311939"],"award-info":[{"award-number":["311939"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["503\/3-015-01\/503-31-001-19-00"],"award-info":[{"award-number":["503\/3-015-01\/503-31-001-19-00"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["294227"],"award-info":[{"award-number":["294227"]}],"id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["294229"],"award-info":[{"award-number":["294229"]}],"id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["307057"],"award-info":[{"award-number":["307057"]}],"id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["311939"],"award-info":[{"award-number":["311939"]}],"id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["503\/3-015-01\/503-31-001-19-00"],"award-info":[{"award-number":["503\/3-015-01\/503-31-001-19-00"]}],"id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["294227"],"award-info":[{"award-number":["294227"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["294229"],"award-info":[{"award-number":["294229"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["307057"],"award-info":[{"award-number":["307057"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["311939"],"award-info":[{"award-number":["311939"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["503\/3-015-01\/503-31-001-19-00"],"award-info":[{"award-number":["503\/3-015-01\/503-31-001-19-00"]}],"id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["294227"],"award-info":[{"award-number":["294227"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["294229"],"award-info":[{"award-number":["294229"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["307057"],"award-info":[{"award-number":["307057"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["311939"],"award-info":[{"award-number":["311939"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["503\/3-015-01\/503-31-001-19-00"],"award-info":[{"award-number":["503\/3-015-01\/503-31-001-19-00"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cbi.2021.109560","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:04:33Z","timestamp":1623985473000},"page":"109560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosis"],"prefix":"10.1016","volume":"345","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7526-0419","authenticated-orcid":false,"given":"Janne","family":"Tampio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Markowicz-Piasecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1175-8517","authenticated-orcid":false,"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109560_bib1","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","article-title":"Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal","volume":"1863","author":"Kandimalla","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.cbi.2021.109560_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer's disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.cbi.2021.109560_bib3","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.3346\/jkms.2019.34.e297","article-title":"Regulation of diabetes: a therapeutic strategy for alzheimer's disease?","volume":"34","author":"Ahn","year":"2019","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.cbi.2021.109560_bib4","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3390\/ijms21082744","article-title":"The interplay between diabetes and alzheimer's disease-in the hunt for biomarkers","volume":"21","author":"Kubis-Kubiak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109560_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","article-title":"Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?","volume":"71","author":"Akter","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109560_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11892-017-0930-z","article-title":"Targeting innate immunity for type 1 diabetes prevention","volume":"17","author":"Needell","year":"2017","journal-title":"Curr. Diabetes Rep."},{"issue":"Suppl 2","key":"10.1016\/j.cbi.2021.109560_bib7","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dcS15-3015","article-title":"Anti-inflammatory agents in the treatment of diabetes and its vascular complications","volume":"39","author":"Pollack","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2021.109560_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2021.109560_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.coi.2007.04.011","article-title":"Delivering the kiss of death: progress on understanding how perforin works","volume":"19","author":"Pipkin","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cbi.2021.109560_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ni.2050","article-title":"Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells","volume":"12","author":"Thiery","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cbi.2021.109560_bib11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/eji.1830051205","article-title":"Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes: conjugation, killing and recycling at the single cell level","volume":"5","author":"Zagury","year":"1975","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cbi.2021.109560_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.186.7.989","article-title":"Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice","volume":"186","author":"Kagi","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cbi.2021.109560_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/cdd.2009.165","article-title":"The role of perforin and granzymes in diabetes","volume":"17","author":"Thomas","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2021.109560_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/NEN.0b013e3181b5417e","article-title":"Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis","volume":"68","author":"Deb","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cbi.2021.109560_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00985-16","article-title":"Perforin expression by CD8 T cells is sufficient to cause fatal brain edema during experimental cerebral malaria","volume":"85","author":"Huggins","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cbi.2021.109560_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1528-1167.2011.03080.x","article-title":"Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures","volume":"52","author":"Marchi","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.cbi.2021.109560_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111401","article-title":"Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption","volume":"9","author":"Johnson","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2021.109560_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s12035-016-9685-9","article-title":"Perforin promotes amyloid beta internalisation in neurons","volume":"54","author":"Lana","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cbi.2021.109560_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.187.4.451","article-title":"Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense","volume":"187","author":"Gasque","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cbi.2021.109560_bib20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2017.01.150","article-title":"Participation of perforin in mediating dopaminergic neuron loss in MPTP-induced Parkinson's disease in mice","volume":"484","author":"Peng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2021.109560_bib21","doi-asserted-by":"crossref","first-page":"16784","DOI":"10.1523\/JNEUROSCI.1867-14.2014","article-title":"Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke","volume":"34","author":"Mracsko","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2021.109560_bib22","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/acs.molpharmaceut.6b00217","article-title":"Systemic and brain pharmacokinetics of perforin inhibitor prodrugs","volume":"13","author":"Gynther","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2021.109560_bib23","doi-asserted-by":"crossref","first-page":"12860","DOI":"10.1038\/s41598-019-49009-z","article-title":"L-type Amino acid transporter 1 (LAT1\/Lat1)-Utilizing prodrugs can improve the delivery of drugs into neurons, astrocytes and microglia","volume":"9","author":"Huttunen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2021.109560_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2015.12.034","article-title":"L-Type amino acid transporter 1 (lat1)-mediated targeted delivery of perforin inhibitors","volume":"498","author":"Huttunen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cbi.2021.109560_bib25","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s12035-020-02045-7","article-title":"Targeting of perforin inhibitor into the brain parenchyma via a prodrug approach can decrease oxidative stress and neuroinflammation and improve cell survival","volume":"57","author":"Tampio","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cbi.2021.109560_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bioorg.2019.03.036","article-title":"Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines","volume":"87","author":"Markowicz-Piasecka","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2021.109560_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejphar.2017.06.011","article-title":"New prodrugs of metformin do not influence the overall haemostasis potential and integrity of the erythrocyte membrane","volume":"811","author":"Markowicz-Piasecka","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109560_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbi.2017.12.005","article-title":"Biocompatible sulfenamide and sulfonamide derivatives of metformin can exert beneficial effects on plasma haemostasis","volume":"280","author":"Markowicz-Piasecka","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109560_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1083\/jcb.200210158","article-title":"Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis","volume":"160","author":"Metkar","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cbi.2021.109560_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1074-7613(03)00032-3","article-title":"Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition","volume":"18","author":"Goping","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2021.109560_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.07.001","article-title":"Regulation of expression and trafficking of perforin-2 by LPS and TNF-\u03b1","volume":"320","author":"Xiong","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cbi.2021.109560_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bmcl.2015.12.003","article-title":"Diarylthiophenes as inhibitors of the pore-forming protein perforin","volume":"26","author":"Miller","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2021.109560_bib33","series-title":"Test Procedures for the Blood Compatibility of Biomaterials","author":"Dawids","year":"1993"},{"key":"10.1016\/j.cbi.2021.109560_bib34","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.carbpol.2010.10.022","article-title":"Biocompatibility and characteristics of injectable chitosan-based thermosensitive hydrogel for drug delivery","volume":"83","author":"Zhou","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.cbi.2021.109560_bib35","first-page":"425","article-title":"[Transformations of erythrocytes shape and its regulation]","volume":"55","author":"Stasiuk","year":"2009","journal-title":"Postepy Biochem."},{"key":"10.1016\/j.cbi.2021.109560_bib36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10495-020-01603-7","article-title":"Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis","volume":"25","author":"Markowicz-Piasecka","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2021.109560_bib37","doi-asserted-by":"crossref","first-page":"119585","DOI":"10.1016\/j.ijpharm.2020.119585","article-title":"L-type amino acid transporter 1 (LAT1)-utilizing efflux transporter inhibitors can improve the brain uptake and apoptosis-inducing effects of vinblastine in cancer cells","volume":"586","author":"Montaser","year":"2020","journal-title":"Int. J. Pharm."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721001988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721001988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:06:24Z","timestamp":1757858784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721001988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":37,"alternative-id":["S0009279721001988"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109560","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosis","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109560"}}